Effect of NK-104, a new synthetic HMG-CoA reductase inhibitor, on triglyceride secretion and fatty acid oxidation in rat liver

This publication has 18 references indexed in Scilit:

• Increased Secretion of Triglyceride and Cholesterol following Inhibition of Long-Chain Fatty Acid Oxidation in Rat Liver
  Annals of Nutrition and Metabolism, 1996
• Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models
  Atherosclerosis, 1995
• The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
• Ameliorative effect of dietary probucol on polychlorinated biphenyls-induced hypercholesterolemia and lipid peroxidation in the rat
  Life Sciences, 1994
• Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
  JAMA, 1993
• Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: Evidence for reduced assembly and secretion of triglyceride-rich lipoproteins
  Metabolism, 1992
• HMG CoA reductase inhibitors
  Current Opinion in Lipidology, 1992
• Cholesterol is required for the secretion of the very-low-density lipoprotein: in vivo studies
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
• Effect of CS-514 (pravastatin) on VLDL-triglyceride kinetics in rats
  Atherosclerosis, 1988
• CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986